Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1976 Aug;52(610):487–481. doi: 10.1136/pgmj.52.610.487

Exertional hypotension due to postganglionic sympathetic blocking drugs.

S Talbot, G W Gill
PMCID: PMC2496447  PMID: 981091

Abstract

Debrisoquine, guanethidine and bethanidine may produce troublesome hypotensive symtoms related to exertion. Thirteen patients with such symptoms were exercised on a treadmill and the response of blood pressure and heart rate was compared to that of thirty patients without these symptoms, who were exercised to the same extent. There was a slight drop of systolic and diastolic pressures on standing in both groups, but after exertion there was a significantly greater drop of systolic pressure in the group with symptoms than in the asymptomatic group. The diastolic pressure after exertion was significantly lower in the group with symptoms. It was impossible to predict from the standing blood pressure levels at rest which patients would develop hypotensive symptoms after exertion. All three drugs had a similar negative chronotropic effect at rest and on exercise. It is suggested that patients are exercised during control of hypertension in order to identify those prone to exertional hypotension. Patients with such hypotension should be exercised on each attendance before the blood pressure is measured. Treatment other than postganglionic sympathetic blocking drugs should be employed whenever possible in patients with milder hypertension.

Full text

PDF
487

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bruce R. A., Kusumi F., Hosmer D. Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. Am Heart J. 1973 Apr;85(4):546–562. doi: 10.1016/0002-8703(73)90502-4. [DOI] [PubMed] [Google Scholar]
  2. DOLLERY C. T., EMSLIE-SMITH D., MILNE M. D. Clinical and pharmacological studies with guanethidine in the treatment of hypertension. Lancet. 1960 Aug 20;2(7147):381–387. doi: 10.1016/s0140-6736(60)92836-1. [DOI] [PubMed] [Google Scholar]
  3. Ewing D. J., Irving J. B., Kerr F., Kirby B. J. Static exercise in untreated systemic hypertension. Br Heart J. 1973 Apr;35(4):413–421. doi: 10.1136/hrt.35.4.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. GAFFNEY T. E., BRAUNWALD E., COOPER T. Analysis of the acute circulatory effects of guanethidine and bretylium. Circ Res. 1962 Jan;10:83–88. doi: 10.1161/01.res.10.1.83. [DOI] [PubMed] [Google Scholar]
  5. Hoel B. L., Lorentsen E., Lund-Larsen P. G. Haemodynamic responses to sustained hand-grip in patients with hypertension. Acta Med Scand. 1970 Dec;188(6):491–495. doi: 10.1111/j.0954-6820.1970.tb08074.x. [DOI] [PubMed] [Google Scholar]
  6. Jacono A., Vitale P., De Divitiis O., Perna N. Le modificzaioni emodinamiche indotte dal blocco dei ricettori beta valutate mediante la manovra di Valsalva. Cuore Circ. 1967 Jun;51(3):129–144. [PubMed] [Google Scholar]
  7. Kahler R. L., Gaffney T. E., Braunwald E. THE EFFECTS OF AUTONOMIC NERVOUS SYSTEM INHIBITION ON THE CIRCULATORY RESPONSE TO MUSCULAR EXERCISE. J Clin Invest. 1962 Nov;41(11):1981–1987. doi: 10.1172/JCI104656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Khatri I. M., Cohn J. N. Mechanism of exercise hypotension after sympathetic blockade. Am J Cardiol. 1970 Mar;25(3):329–338. doi: 10.1016/s0002-9149(70)80011-x. [DOI] [PubMed] [Google Scholar]
  9. Káldor A., Juvancz P. Effect of antihypertensive drugs on the "intrinsic" heart rate. Br Med J. 1969 May 24;2(5655):486–487. doi: 10.1136/bmj.2.5655.486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. MOE R. A., BATES H. M., PALKOSKI Z. M., BANZIGER R. CARDIOVASCULAR EFFECTS OF 3,4-DIHYDRO-2(1H) ISOQUINOLINE CARBOXAMIDINE (DECLINAX-T.M.). Curr Ther Res Clin Exp. 1964 Apr;6:299–318. [PubMed] [Google Scholar]
  11. Onesti G., LaSchiazza D., Brest A. N., Moyer J. H. Cardiac and renal hemodynamic effects of debrisoquin sulfate in hypertensive patients. Clin Pharmacol Ther. 1966 Jan-Feb;7(1):17–20. doi: 10.1002/cpt19667117. [DOI] [PubMed] [Google Scholar]
  12. Prichard B. N., Johnston A. W., Hill I. D., Rosenheim M. L. Bethanidine, Guanethidine, and Methyldopa in Treatment of Hypertension: a Within-patient Comparison. Br Med J. 1968 Jan 20;1(5585):135–144. doi: 10.1136/bmj.1.5585.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. SOKOLOW M., LYON T. P. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949 Feb;37(2):161–186. doi: 10.1016/0002-8703(49)90562-1. [DOI] [PubMed] [Google Scholar]
  14. Sandler G., Leishman A. W., Humberstone P. M. Guanethidine-resistant hypertension. Circulation. 1968 Sep;38(3):542–551. doi: 10.1161/01.cir.38.3.542. [DOI] [PubMed] [Google Scholar]
  15. TAYLOR S. H., DONALD K. W., BISHOP J. M. Circulatory studies in hypertensive patients at rest and during exercise, with a note on the Starling relationship in the left ventricle in essential hypertension. Clin Sci. 1957 May;16(2):351–376. [PubMed] [Google Scholar]
  16. Talbot S., Smith A. J. Factors predisposing to postural hypotensive symptoms in the treatment of high blood pressure. Br Heart J. 1975 Oct;37(10):1059–1063. doi: 10.1136/hrt.37.10.1059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. VERNIKOS-DANELLIS J., ZAIMIS E. Some pharmacological actions of bretylium and guanethidine. Lancet. 1960 Oct 8;2(7154):787–788. doi: 10.1016/s0140-6736(60)91856-0. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES